Urodynamix Awarded NRC-IRAP Support For New Prostate Cancer Detection Technology, Canada

Urodynamix Technologies Ltd. (TSX-V:URO) announced that it has received a non-refundable financial contribution from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to help accelerate the development and commercialization of new NIRS technology for the detection of prostate cancer during the digital rectal examination, or DRE.

More: continued here

Filed under: Prostate on September 8th, 2008